J Korean Acad Rehabil Med.  2007 Apr;31(2):207-212.

Effects of the Combined Therapy with Raloxifene and Low-Dose Intermittent Fluoride for Two Years in Postmenopausal Women with Osteoporosis

• Chung SM
• Kim GC

Abstract

OBJECTIVE
To compare the effects of raloxifene alone with a combination of raloxifene and fluoride in postmenopausal osteoporosis on bone mineral density, bone turnover and lipid profiles, at 2 year. METHOD: Fifty two women with postmenopausal osteoporosis (T-score < 2.5) were studied. Subjects were divided into two groups; Group I (n=23), treated with raloxifene and fluoride, and Group II (n=29), treated with raloxifene alone. Bone mineral density (BMD) at the lumbar spine and femur, osteocalcin, deoxypyridinoline and lipid profiles were measured at baseline and 2 years after treatment.
RESULTS
BMD at the lumbar spine was increased in two groups, and BMD in Group I was increased more than that in Group II. Osteocalcin was increased in Group I, and was decreased in Group II. Deoxypyridinoline was decreased in two groups. Total cholesterol and LDL cholesterol were decreased in two groups, but HDL cholesterol and triglyceride showed no significant change in two groups. There were no significant differences between two groups in lipid profiles.
CONCLUSION
The combined therapy with raloxifene and low- dose intermittent fluoride was more effective in postmenopausal women with osteoporosis than raloxifene alone, which would not influence on positive effect of raloxifene for lipid metabolism.

Keyword

Postmenopausal osteoporosis; Raloxifene; Fluoride

MeSH Terms

Bone Density
Cholesterol
Cholesterol, HDL
Cholesterol, LDL
Female
Femur
Fluorides*
Humans
Lipid Metabolism
Osteocalcin
Osteoporosis*
Osteoporosis, Postmenopausal
Raloxifene Hydrochloride*
Spine
Triglycerides
Cholesterol
Cholesterol, HDL
Cholesterol, LDL
Fluorides
Osteocalcin